Georgotas 1986.
Methods | Double blind RCT. Concealment of allocation ‐ unclear. Analysis: Endpoint Active treatment: 7 weeks | |
Participants | Inclusion criteria: RDC Major Depression and 16+ HMD Age: over 55 Country: USA Setting: Outpatient | |
Interventions | Nortriptyline versus phenelzine | |
Outcomes | Side effects Drop out | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |